Merck KGaA Eyes Acquisitions To Beef Up All Four Business Divisions

Germany's Merck KGaA (MRCG.DE) said it would look into possible acquisitions to strengthen all of its four business divisions - prescription drugs, non-prescription drugs, laboratory equipment and specialty chemicals. "We have four sustainable business divisions that are set to grow organically, but for all four areas we have ideas for steps that go beyond that," Chief Executive Karl-Ludwig Kley told journalists at a press conference on Thursday.

Help employers find you! Check out all the jobs and post your resume.